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were generated and digitized. The H&E sections were registered to 
the MRI with a registration-error less than 3 mm. Spearman’s 
correlation between tumor ADC and micro anatomical variables were 
calculated using an automatic pixel counting algorithm 
(AperioTechnologies) (Figure 1). 
 
  
Results: ADC was significantly and inversely correlated to cell density, 
percentage area of nuclei and N/C ratio. ADC was significantly and 
positively related to percentage area of stroma. Additionally, the 
percentage area of stroma was strongly interdependent with the 
percentage area of nuclei (Table 1). 
 
  
Conclusions: ADC was significantly correlated with cellularity, stromal 
component and the nuclear-to-cytoplasm ratio. These results give us 
insights into how ADC reflects the underlying microanatomical 
environment. The correlation between stromal component, a known 
predictor of local failure, and ADC might suggest that the poor 
prognostic value of a high pre-treatment ADC might partly be 
attributed to the tumor-stroma component. 
[1]Hakatenaka et al, Int J Radiat Oncol Biol Phys. 2011 
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Purpose/Objective: Dynamic contrast enhanced CT imaging 
('perfusion CT') is a technique for the quantification of vasculature 
inside tumours. If combined with FDG-PET/CT imaging a more 
complete assessment of the tumour heterogeneity is possible. In this 
study we investigated non-small cell lung cancer (NSCLC) patients 
undergoing both techniques on the same day to quantify the 
correlation of vasculature properties with metabolically active 
regions. 
Materials and Methods: A total of 12 patients diagnosed with stage II-
III NSCLC were analysed from two ongoing clinical trials (NCT01024829 
and NCT01210378) prior to (chemo-)radiotherapy treatment were 
scheduled for FDG-PET/CT (Siemens Biograph 40 PET/CT) and 
perfusion CT (Siemens Definition Flash CT) imaging. The primary gross 
tumour volume (GTV) was delineated on the PET/CT scan for 
treatment planning purposes. Datasets of both imaging modalities 
(FDG-PET/CT and perfusion CT) were registered and metabolic uptake 
regions on the FDG-PET/CT were thresholded in 2 regions inside the 
GTV: a low (0-50% of the maximum SUV) and high metabolic uptake 
(>50% of the maximum SUV). Commercial perfusion CT software 
(Siemens VPCT; deconvolution algorithm approach) was used to 
extract inside the 2 thresholded regions the vasculature properties op 
the tumour: blood flow (BF), blood volume (BV), permeability (PMB) 
and mean transit time (MTT). Differences in vasculature between low 
and high uptake volumes were assessed. 
Results: Differences (mean±1SD) were observed between low and high 
metabolically active regions: average BF (ml/100ml/min) 52±33 vs. 
68±39 ml/100ml/min (p=0.03), average BV (ml/100ml) was 6.6±4.4 vs. 
9.3±6.0 (p=0.06), MTT 5.8±3.8 vs. 6.0±4.1 s (p=0.62) and PMB 
(ml/100ml/min) was 13±19 vs. 20±27 (p<0.01), respectively. 
Conclusions: Regions that are metabolically active on the FDG-PET 
scan also show increased blood flow, volume and permeability 
indicating more vascularised tumour parts. Mean transit times for the 
contrast were not different. These findings yield the potential to use 
perfusion imaging for characterization of vasculature in staging and 
follow-up of NSCLC patients scheduled for multi-modality therapy.  
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Purpose/Objective: Tumour hypoxia is an important marker of cancer 
prognosis, being associated with aggressive growth, metastasis and 
resistance to anticancer therapy. Imaging of tumour hypoxia could 
help to select patients for anti-hypoxia therapy and/or for a radiation 
boost to the hypoxic tumour regions. Pre-clinical data and phase I 
human trials have shown that [18F]HX4 is a novel promising Positron 
Emission Tomography (PET) tracer for the evaluation of tumour 
hypoxia. The aims of the study were to evaluate the [18F]HX4 uptake, 
the optimal imaging time-point after injection and the spatiotemporal 
stability in NSCLC patients. 
Materials and Methods: 13 NSCLC patients (stage IIB-IV) included in 2 
clinical trials (NCT01024829 and NCT01210378) were imaged on a 
PET/CT scanner using the hypoxia tracer: [18F]HX4. 413±71 MBq of 
[18F]HX4 was injected intravenously and at 2 and 4 hours p.i. PET 
acquisitions (30 min static) were acquired. SUV-max and SUVmean were 
extracted from the gross tumour volumes (GTVs) and aortic arch to 
calculate tumour-to-blood ratios (TBR). The Wilcoxon signed rank test 
was used to determine significant differences in uptake between 2h 
and 4h post injection (p.i.) The tumour hypoxic fraction (HF), defined 
as the fraction of the GTV with a TBR>1.4, was determined for all 
lesions (i.e. primary tumour and lymph nodes). To evaluate the 
spatiotemporal stability, images acquired at 2h and 4h p.i. were 
rigidly registered and a voxelwise comparison of the [18F]HX4 uptake 
was made, expressed as a Pearson correlation coefficient. 
Results: Analysis of the first 13 NSCLC patients (9 male, 4 female, 
age: 62±12 y), indicated significant uptake (TBR>1.4) in 18/25 target 
lesions (13 primary tumours and 12 lymph nodes) with an average HF 
of 20±21% (range: 0.2-71%) at 4h p.i.. 85% (11/13) of the primary 
tumours and 58% (7/12) of the involved lymph nodes were hypoxic. 
There was no correlation between the GTV and HF (R=0.25, P=0.24). 
Within the 18 hypoxic lesions, the average tumour SUVmax decreased 
significantly (P=0.004) from 2h (1.4±0.4) to 4h p.i. (1.2±0.4). 
However, due to clearance of [18F]HX4 in the blood, the TBR increased 
significantly (P<0.001) between 2h and 4h p.i. from 1.6±0.3 to 2.0±0.5 
(see figure). The heterogeneous [18F]HX4 uptake pattern at 2h and 4h 
p.i. showed a strong correlation (R=0.76±0.09, range: 0.58-0.94). 
 
  
Conclusions: Significant hypoxia was observed in 72% of the NSCLC 
target lesions (85% of primary tumours and 58% of the involved lymph 
nodes). The heterogeneous [18F]HX4 uptake pattern was stable 
between 2h and 4h p.i., however the TBR increased over time, 
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suggesting that imaging at 4 hours p.i. is optimal to reach the highest 
contrast in [18F]HX4 PET images.  
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Purpose/Objective: To improve PET/CT image quality for small liver 
tumors by compensating breathing-induced motion. 
Materials and Methods: On our Philips Gemini PET/CT system, we 
acquired 4D CT and 4D PET scans for 6 patients by registering the 
breathing signal during the acquisition and binning the data into 10 
phase bins. The 4D CT dataset was used as an input for our home-
made implementation of a phase-based optical-flow method to 
determine the deformation vector field (DVF) between succeeding 
breathing phase bins. By subtracting the average of the 10 DVFs from 
each individual DVF, each phase could be mapped to the time-
weighted, averaged position.For each voxel in this averaged position, 
the median of the HU values of the 10 mapped phases was taken as a 
representative value for that voxel. This results in the 3D Mid Position 
(MidP) CT scan. In the same way all 10 phases of the 4DPET data were 
deformed based on the CT DVFs. In that case the average of the SUV 
for all 10 phases was taken, resulting in a MidP PET scan.  
Additionally, the PET scan was reconstructed in 3D in the conventional 
way, that is, without motion compensation. 
We overlaid the MidP PET and CT images to look for errors in the 
registration.  
For CT we determined the standard deviation in HU within a 
homogeneous part in the liver (Black circle) for the ten separate 
phases and the MidP scan and compared these. For PET we 
determined the standard deviation in SUV within the tumor region, 
indicated by the white circle, both for the conventional 3D PET scan 
and the MidP PET scan. Additionally, we determined the decrease in 
volume enclosed by 50% SUVmax comparing the conventional 3D with 
the MidP PET datasets. 
Results: The motion of the tumor due to breathing was on average 1.8 
(σ = 0.7)cm. The relative decrease in standard deviation in a 
homogeneous region in the original 4D CT data was about 67 (σ = 8)%. 
The standard deviation in the PET signal within the tumor showed an 
increase of about 5 (σ = 8)%. The PET values within the tumor region 
are in general not evenly distributed. In the conventional3D 
reconstruction this contrast is decreased due to motion blurring; for 
the motion compensated MidP PET dataset it is not. Therefore, the 
standard deviation in the MidP PET scan may be higher compared to 
the conventional 3Dscan. The volume decrease was on average 8% (σ = 
12%). It should be noted that for 4 of the lesions the decrease was 
almost zero, whereas for others the decrease was over 30%. 
Overall, more details could be seen on both CT and PET scan (see 
figure). 
Conclusions: Motion compensation in 4D PET/CT is feasible and 
increases image quality. The size of the lesions shown on the motion-
compensated PET images can decrease considerably compared to the 
conventional, non-compensated 3D PET scan.  
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Purpose/Objective: Dynamic contrast enhanced MRI (DCEMRI) of 
locally advanced cervical cancers and pharmacokinetic image analysis 
may be used to identify patients at risk of local relapse [1]. 
Furthermore, a pharmacokinetic image parameter, ABrix, has been 
shown to correlate with an hypoxic gene signature in such tumors [2]. 
Thus, DCEMRI may be used to identify patients with hypoxic disease 
and potentially to distinguish hypoxic from normoxic tissue. 
Therefore, it is of interest to explore strategies taking such biological 
image information into account to improve radiotherapy outcome. 
Materials and Methods: DCEMR images of 23 patients with locally 
advanced cervical cancers were used. The dynamic image series were 
analyzed in terms of the pharmacokinetic ‘Brix’ model voxel byvoxel 
in each patient. The resulting ABrix maps were imported into Oncentra 
Brachy (Nucletron, the Netherlands) and used to define an hypoxic, or 
biological, target volume (BTV). T2-weighted images were used to 
define the gross tumor volume (GTV). Using a ring applicator, 
including needles when necessary, two brachytherapy treatment 
planning approaches were investigated. In approach 1, a conventional, 
non-biological image guided approach was followed where GTV was 
given the highest dose possible without compromising the dose 
constraints for the organs at risk. In approach 2, BTV was boosted to 
the highest dose possible, still without compromising other dose 
objectives. The results were analyzed in terms of D90 (fraction dose to 
90% of volume) to the targets. 
Results: The patients presented highly different hypoxic BTVs, both in 
size and location within the GTV. The hypoxic fraction (BTV/GTV 
volume ratio) ranged from 0.06 to 0.86. For some patients, it was 
possible to escalate the dose to the BTV (approach 2) with up to 30 % 
compared to approach 1, while others could not be further escalated 
without violating the dose constrains to the OARs. For approach 1, D90 
to GTV was 9.7±2.0 Gy while D90 for BTV was 11.2±2.9 Gy (cohort-
based mean ± 1 s.d.). Following approach 2, these D90’s were 
10.1±2.3Gy and 12.2±3.4Gy, respectively.  
Conclusions: In conventional image guided brachytherapy, the 
hypoxic subvolume usually receives a higher dose than the rest of the 
GTV. Further dose escalation is possible for a selection of patients 
with small and/or centrally located hypoxic BTVs. 
[1] E. Andersen, K.H. Hole, K.V. Lund et al. Pharmacokinetic 
parameters derived from dynamic contrast enhanced MRI of cervical 
cancers predict chemoradiotherapy outcome. Radiother Oncol 
(accepted). 
[2] C. Halle, E. Andersen, M. Lando et al. Hypoxia-Induced Gene 
Expression in Chemoradioresistant Cervical Cancer Revealed by 
Dynamic Contrast-Enhanced MRI. Cancer Res 2012; 72: 5285-5295. 
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Purpose/Objective: Understanding the etiology of tumor response is 
the key to adaptive radiotherapy. Both Dynamic Contrast Enhanced 
(DCE)-MRI and Diffusion Weighted (DW)-MRI are techniques to gain 
information about the microenvironment of tumors. Combining these 
two techniques opens the possibility to investigate wherethey carry 
similar and complimentary information.  
Materials and Methods: A 3T MRI (Philips Achieva 3T-X) was used 
before start of EBRT in 8 patients with locally advanced cervical 
cancer. DCE-MRI: 20-24slices, 5mm slice thickness, TE/TR: 1.4ms/2.9 
ms, 10o Flip Angle(FA), 2.27mm isotropic in-plane resolution . The 
bolus injected was 0.1mmol/kg Dotarem at 4ml/s, followed by a 5 ml 
saline flush. 120 dynamic acquisitions, equidistantly spaced by 2.1 
sec, were acquired. DWI-MRI: b=[150, 600, 1.000]s/mm2 TR = 1613 ms, 
TE=75 ms, the number of averages 6, matrix size was 112x112, 
resolution 2.5x2.5x4 mm. T2w images were used for tumor 
delineation. A moving average with a kernel of 0.15cc was applied to 
the images before post processing. The extended Tofts and Brix 
models were performed on the DCE-MRI. ADC was calculated assuming 
a log-linear relation between signal intensity and b-values. The 
correlation between perfusion parameters (Ktrans,ve,vp,ABrix,RSI90) and 
ADC was based on all voxels (figure 1) and evaluated using the Pearson 
correlation coefficient (r). 
Results: 
